Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin

CA Bradfield, AS Kende and A Poland

McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.

In this report, we have used the radioligand [125I]2-iodo-7,8-dibromo- dibenzo-p-dioxin to describe the kinetics of ligand binding to the Ah receptor prepared from C57BL/6J mouse liver. The higher specific activity of this radioligand (2176 Ci/mmol), compared with the usual tritiated ligand [1,6-3H]2,3,7,8-tetrachloro-dibenzo-p-dioxin (58 Ci/mmol) permitted the study of ligand-receptor interactions at much lower component concentrations. For this radioiodinated ligand, Scatchard analysis of saturation binding curves, determined at six different protein concentrations, indicated that the apparent equilibrium dissociation constant, KD, was directly related to the dilution of the receptor preparation; for example, at 1160 micrograms of protein/ml, KD = 1.6 x 10(-10) M; at 36 micrograms of protein/ml, KD = 1.2 x 10(-11) M. Extrapolation of this function to infinite receptor dilution yielded KD = 6 x 10(-12) M. The addition of 70 micrograms/ml of bovine serum albumin to a receptor preparation of 30 micrograms of protein/ml produced a 10-fold decrease in the slope of the Scatchard plot (i.e., 10-fold increase in the apparent KD). Conversely, enrichment of the receptor by high performance liquid chromatography led to an increased slope and thus decreased estimate of KD. The association rate constant (k1), calculated from the integrated second- order rate equation, was 2.8 x 10(10) M-1 hr-1 and, from the initial velocity equation, had a value of 5.25 x 10(10) M-1 hr-1. The dissociation rate constant was biphasic, consisting of a predominant fast component with a rate constant of 0.36 hr-1 (k-1) and a slower component with a rate constant of 4.2-9.4 x 10(-3) hr-1 (k-2). Higher protein concentrations produced a decrease in estimates of k1 but not k- 1 or k-2. The KD determined from the ratio of the kinetic rate constant, k-1/k1 = 6.9 x 10(-12) M, is in excellent agreement with that derived from the results of equilibrium binding experiments extrapolated to infinite dilution, KD = 6 x 10(-12) M. The decrease in KD, observed in equilibrium binding studies upon dilution of the receptor preparation, is best explained by a more accurate classification of "free" radioligand at lower protein concentrations. Finally, ligand binding to the Ah receptor is best described by a two- step process, the formation of an initial complex, characterized by rapid ligand dissociation, which undergoes transformation to a second distinct complex displaying a much slower ligand dissociation rate.

Volume 34, Issue 2, pp. 229-237, 08/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. E. Bohonowych and M. S. Denison Persistent Binding of Ligands to the Aryl Hydrocarbon Receptor Toxicol. Sci., July 1, 2007; 98(1): 99 - 109. [Abstract] [Full Text] [PDF]

				E. E. Dunham, E. A. Stevens, E. Glover, and C. A. Bradfield The Aryl Hydrocarbon Receptor Signaling Pathway Is Modified through Interactions with a Kelch Protein Mol. Pharmacol., July 1, 2006; 70(1): 8 - 15. [Abstract] [Full Text] [PDF]

				J. A. Lavine, A. J. Rowatt, T. Klimova, A. J. Whitington, E. Dengler, C. Beck, and W. H. Powell Aryl Hydrocarbon Receptors in the Frog Xenopus laevis: Two AhR1 Paralogs Exhibit Low Affinity for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Toxicol. Sci., November 1, 2005; 88(1): 60 - 72. [Abstract] [Full Text] [PDF]

				T. L. Thomae, E. Glover, and C. A. Bradfield A Maternal Ahr Null Genotype Sensitizes Embryos to Chemical Teratogenesis J. Biol. Chem., July 16, 2004; 279(29): 30189 - 30194. [Abstract] [Full Text] [PDF]

				P. Ramadoss and G. H. Perdew Use of 2-Azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin as a Probe to Determine the Relative Ligand Affinity of Human versus Mouse Aryl Hydrocarbon Receptor in Cultured Cells Mol. Pharmacol., July 1, 2004; 66(1): 129 - 136. [Abstract] [Full Text] [PDF]

				J. A. Walisser, M. K. Bunger, E. Glover, E. B. Harstad, and C. A. Bradfield Patent Ductus Venosus and Dioxin Resistance in Mice Harboring a Hypomorphic Arnt Allele J. Biol. Chem., April 16, 2004; 279(16): 16326 - 16331. [Abstract] [Full Text] [PDF]

				M. K. Bunger, S. M. Moran, E. Glover, T. L. Thomae, G. P. Lahvis, B. C. Lin, and C. A. Bradfield Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicity and Abnormal Liver Development in Mice Carrying a Mutation in the Nuclear Localization Sequence of the Aryl Hydrocarbon Receptor J. Biol. Chem., May 9, 2003; 278(20): 17767 - 17774. [Abstract] [Full Text] [PDF]

				B. A. Jensen and M. E. Hahn cDNA Cloning and Characterization of a High Affinity Aryl Hydrocarbon Receptor in a Cetacean, the Beluga, Delphinapterus leucas Toxicol. Sci., November 1, 2001; 64(1): 41 - 56. [Abstract] [Full Text] [PDF]

				X. Wang, M. J. Santostefano, M. J. DeVito, and L. S. Birnbaum Extrapolation of a PBPK Model for Dioxins across Dosage Regimen, Gender, Strain, and Species Toxicol. Sci., July 1, 2000; 56(1): 49 - 60. [Abstract] [Full Text] [PDF]

				J. J. LaPres, E. Glover, E. E. Dunham, M. K. Bunger, and C. A. Bradfield ARA9 Modifies Agonist Signaling through an Increase in Cytosolic Aryl Hydrocarbon Receptor J. Biol. Chem., February 25, 2000; 275(9): 6153 - 6159. [Abstract] [Full Text] [PDF]